Brachytherapy: Where has it gone?

Journal of Clinical Oncology

Volumn 33, Issue 9, 2015, Pages 980-982

  Petereit, Daniel G ^a   Frank, Steven J ^b   Viswanathan, Akila N ^c   Erickson, Beth ^d   Eifel, Patricia ^b   Nguyen, Paul L ^c   Wazer, David E ^e,f  

^a Rapid City Regional Cancer Center   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MORBIDITY; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; UNITED STATES; UTERINE CERVIX CANCER; EVIDENCE BASED MEDICINE; FEMALE; MALE; ONCOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; TRENDS; UTERINE CERVICAL NEOPLASMS;

BRACHYTHERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84927154471     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.8128     Document Type: Note

References (22)

1. Kavanagh BD, Haffty BG, Tepper JE: Radiation oncology: A snapshot in time, 2014. J Clin Oncol 32:2825-2826, 2014
2. Martin JM, Handorf EA, Kutikov A, et al: The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer 120:2114-2121, 2014
3. Mahmood U, Pugh T, Frank S, et al: Declining use of brachytherapy for the treatment of prostate cancer. Brachytherapy 13:157-162, 2014
4. Han K, Milosevic M, Fyles A, et al: Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys 87:111-119, 2013
5. Gill BS, Lin JF, Krivak TC, et al: National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: The impact of new technological advancements. Int J Radiat Oncol Biol Phys 90:1083-1090, 2014
6. Andriole GL, Crawford ED, Grubb RL 3rd, et al: Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up. J Natl Cancer Inst 104:125-132, 2012
7. D'Amico AV, Renshaw AA, Sussman B, et al: Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 294:440-447, 2005
8. Wilt TJ, Brawer MK, Jones KM, et al: Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203-213, 2012
9. Bill-Axelson A, Holmberg L, Ruutu M, et al: Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977-1984, 2005
10. Lane JA, Donovan JL, Davis M, et al: Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: Study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol 15:1109-1118, 2014
11. Grimm P, Billiet I, Bostwick D, et al: Comparative analysis of prostatespecific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy: Results from the Prostate Cancer Results Study Group. BJU Int 109:22-29, 2012
12. Mitchell JM: Urologists' use of intensity-modulated radiation therapy for prostate cancer. N Engl J Med 369:1629-1637, 2013
13. Bogdanich W: Failed prostate procedures at the Philadelphia VA. New York Times, June 20, 2009
14. Compton JJ, Gaspar LE, Shrieve DC, et al: Resident-reported brachytherapy experience in ACGME-accredited radiation oncology training programs. Brachytherapy 12:622-627, 2013
15. Richardson S: A 2-year review of recent Nuclear Regulatory Commission events: What errors occur in the modern brachytherapy era? Pract Radiat Oncol 2:157-163, 2012
16. Hayes JH, Ollendorf DA, Pearson SD, et al: Observation versus initial treatment for men with localized, low-risk prostate cancer: A cost-effectiveness analysis. Ann Intern Med 158:853-860, 2013
17. Frank SJ, et al: Defining value in prostate brachytherapy. Presented at the University of Texas MD Anderson Cancer Center 2nd International Prostate Brachytherapy Conference: The Value and Future of Prostate Brachytherapy in a Changing Healthcare Environment, Houston, TX, December 7-8, 2013
18. Georg D, Kirisits C, Hillbrand M, et al: Image-guided radiotherapy for cervix cancer: High-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 71:1272-1278, 2008
19. Pötter R, Georg P, Dimopoulos JC, et al: Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 100:116-123, 2011
20. Lindegaard JC, Fokdal LU, Nielsen SK, et al: MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 52:1510-1519, 2013
21. Smith GL, Eifel PJ: Trends in the utilization of brachytherapy in cervical cancer in the United States: In regard to Han et al. Int J Radiat Oncol Biol Phys 88:459-460, 2014
22. Eifel PJ, Ho A, Khalid N, et al: Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: A quality Research in Radiation Oncology study. Int J Radiat Oncol Biol Phys 89:249-256, 2014